e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Pathogenesis and mechanisms of respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The weight of radiological severity in patients with non-CF bronchiectasis
S. Lonni, N. Sverzellati, A. M. Zanaboni, J. D. Chalmers, G. Bonaiti, G. Suigo, S. Annoni, P. Faverio, A. Pesci, S. Aliberti (Milan, Parma, Italy; Dundee, United Kingdom)
Source:
International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Session:
Pathogenesis and mechanisms of respiratory infections
Session type:
Poster Discussion
Number:
4938
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Lonni, N. Sverzellati, A. M. Zanaboni, J. D. Chalmers, G. Bonaiti, G. Suigo, S. Annoni, P. Faverio, A. Pesci, S. Aliberti (Milan, Parma, Italy; Dundee, United Kingdom). The weight of radiological severity in patients with non-CF bronchiectasis. Eur Respir J 2014; 44: Suppl. 58, 4938
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
ERS clinical practice guidelines on bronchiectasis in children
Related content which might interest you:
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Microbial aetiology and outcomes of CAP in bronchiectatic patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Pneumonic vs. non-pneumonic exacerbations in bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Etiology and outcome of bronchiectasis in children
Source: International Congress 2014 – Paediatric bronchology
Year: 2014
Diagnosis and aetiological treatment of bronchiectasis in adult patients
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept